BioSpace News Archive

Business

Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets

Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis.

March 5, 2020
·
3 min read
Business

VBI Vaccines Provides Corporate Update, Outlook for 2020, and Year-End 2019 Financial Results

VBI Vaccines Inc. (Nasdaq: VBIV)(VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today provided a corporate update, its outlook for 2020, and announced financial results for the fourth quarter and twelve months ended December 31, 2019

March 5, 2020
·
14 min read
Biotech Beach

Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder

Urovant Sciences (Nasdaq: UROV) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the treatment of patients with overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

March 5, 2020
·
5 min read
Enlivex Therapeutics Closes $16.75 Million Registered Direct Offering

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the closing of its previously announced registered direct offering to certain accredited and healthcare-focused institutional investors, including Armistice Capital, of an aggregate of 2,093,750 ordinary shares of the Company and warrants to purchase up to an aggregate of 2,093,750 ordinary shares at a combined purchase price of $8.00 per share

March 5, 2020
·
4 min read
Business

Heather Rowe Armstrong Joins Arcutis as Vice President of Investor Relations and Corporate Communications

Arcutis Biotherapeutics, Inc . (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Heather Rowe Armstrong has joined the company as Vice President of Investor Relations and Corporate Communications.

March 5, 2020
·
2 min read
Policy

ACHA Releases New Guidelines on Preparing for COVID-19

Guidelines provide colleges and universities with recommendations for preparing for the presence COVID-19 on campus.

March 5, 2020
·
2 min read
Genetown

National Institutes of Health (NIH) chooses Aspera for cost-saving Software Services

Aspera, the leading global provider of solutions and services for Software Asset Management (SAM) and part of the USU Group, today announced that the National Institutes of Health (NIH) has signed a $5 million agreement to use Aspera SAM services

March 5, 2020
·
1 min read
FDA

Allergan Receives FDA Approval for DURYSTA™ (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients

- DURYSTA™ lowered intraocular pressure in patients with open-angle glaucoma or ocular hypertension by approximately 30 percent from baseline in two Phase 3 studies -

March 5, 2020
·
9 min read
Biotech Beach

Institute for Women’s and Children’s Health Launched at The Lundquist Institute

New institute brings together renowned experts focused on biggest health concerns facing women and children

March 5, 2020
·
4 min read
BioMidwest

SOC Telemed Pivots To Virtual Presence For HIMSS 2020 Amidst Spread Of Coronavirus

Leader in Virtual Care Leans in to Remote Capabilities for Customer and Partners

March 5, 2020
·
3 min read